Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open‐label clinical trial ( <scp>RESOLUTION</scp> study)
Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open‐label clinical trial ( <scp>RESOLUTION</scp> study) is a paper indexed in PICO Portal from OpenAlex.
How many citations does Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open‐label clinical trial ( <scp>RESOLUTION</scp> study) have?
Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open‐label clinical trial ( <scp>RESOLUTION</scp> study) has 0 citations in the OpenAlex counts PICO Portal stores.
When was Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open‐label clinical trial ( <scp>RESOLUTION</scp> study) published?
Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open‐label clinical trial ( <scp>RESOLUTION</scp> study) has 2025 year in the PICO Portal index.
What is the open-access status of Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open‐label clinical trial ( <scp>RESOLUTION</scp> study)?
Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open‐label clinical trial ( <scp>RESOLUTION</scp> study) has gold oa status in the PICO Portal index.
What is the DOI of Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open‐label clinical trial ( <scp>RESOLUTION</scp> study)?
The DOI for Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open‐label clinical trial ( <scp>RESOLUTION</scp> study) is on the source record.
What is the PMID of Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open‐label clinical trial ( <scp>RESOLUTION</scp> study)?
The PMID for Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open‐label clinical trial ( <scp>RESOLUTION</scp> study) is on the source record.
What is the OpenAlex record for Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open‐label clinical trial ( <scp>RESOLUTION</scp> study)?
The OpenAlex for Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open‐label clinical trial ( <scp>RESOLUTION</scp> study) is on the source record.